Abstract:The relationship between BRAF‐V600E mutations, mitochondrial DNA amplification and microsatellite instability‐high (MSI‐H) in colorectal cancer (CRC) has yet to be fully elucidated. The aim of the present study was to assess the association between the MSI status and BRAF‐V600E gene mutations/clinicopathological features/mitochondrial DNA amplification in CRC. A non‐interventional study analysis was performed using the clinicopathological features of 455 patients with CRC. Immunohistochemistry was used to evaluate four mismatch repair proteins (MutS homolog 2, MutS homolog 6, MutL homolog 1 and postmeiotic segregation increased 2), Ki‐67 index, and programmed cell death protein 1 (PD‐1) and programmed cell death‐ligand 1 (PD‐L1) expression. Additionally, PCR coupled with capillary electrophoresis were used to ascertain the MSI status. Moreover, amplification refractory mutation system‐PCR was used to detect BRAF‐V600E gene mutation and fluorescence in situ hybridization analysis was used to assess mitochondrial DNA. A total of 455 patients were divided into the MSI high (MSI‐H) group (n=52) and microsatellite stability (MSS) group (n=403) based on their MSI status. Compared with the results of immunohistochemistry of four mismatch repair proteins, the consistency rate between mismatch repair protein deficiency and MSI was 94.23%. There were significant differences in PD‐L1, primary tumor site, clinical stage, degree of differentiation, tumor size, lymph node metastasis and the occurrence of multiple primary tumors between the MSI‐H group and MSS group (P<0.05 or P<0.001). However, there were no significant differences for sex, age, PD‐1, Ki‐67 expression and BRAF‐V600E. The 24‐60‐month survival rate of the patients in the MSI‐H group was significantly higher than that of those in the MSS group (P<0.05). Furthermore, the number of mitochondrial DNA was significantly amplified in the MSI‐H group. In conclusion, the present study demonstrated thatthecombined detection of PD‐L1 and MSI in patients with CRC can provide more accurate and effective guidance for personalized treatment.

Microsatellite instability in sporadic colorectal cancer and its relationship with clinicopathological features

Association of Microsatellite Instability with Clinicopathological Features of Sporadic Colorectal Cancer

Relationship between microsatellite instability and clinicopathological features and prognosis in sporadic colorectal cancer

Microsatellite Instability of Sporadic Colorectal Carcinomas and Its Clinicopathological Significance

[Studies of Microsatellite Instability in Chinese Gastric Cancer Tissues].

[Influence of microsatellite instability on survival of patients with sporadic colorectal cancer in China].

Microsatellite Instability in Sporadic Multiple Primary Colorectal Carcinoma

Clinicopathologic features and DNA ploidy of sporadic colorectal cancers with microsatellite instability

[Detection of microsatellite instability in colorectal cancer by fluorescence multiplex polymerase chain reaction and its clinical value].

Comparison of Microsatellite Instability With Clinicopathologic Data in Patients With Colon Adenocarcinoma

Clinical Implications of Microsatellite Instability in T1 Colorectal Cancer

Microsatellite Instability Testing and Prognostic Implications in Colorectal Cancer

Study on the relationship between microsatellite status and clinicopathological charac-teristics of colorectal cancer patients after surgery

Microsatellite instability in mismatch repair proficient colorectal cancer: clinical features and underlying molecular mechanisms

Clinicopathologic and molecular features of sporadic microsatellite- and chromosomal-stable colorectal cancers

Clinical relevance of microsatellite instability in colorectal cancer

Status and Clinical Value of Microsatellite Instability in Stage Ⅱ Colon Cancer

Clinical Aspects of Microsatellite Instability Testing in Colorectal Cancer

A Novel and Reliable Method to Detect Microsatellite Instability in Colorectal Cancer by Next-Generation Sequencing.

Association between microsatellite instability status, clinicopathological features and mitochondrial DNA amplification in patients with colorectal cancer

Reduced Likelihood of Metastases in Patients with Microsatellite-Unstable Colorectal Cancer